USPTO serial 79376526
GEDITING
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 28, 2025
- Examiner
- CRAVEN, PAUL S
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GEDITING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stephen R. Barrese
Stephen R. Barrese Dilworth & Barrese, LLP48 South Service Road, Suite 200Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Recycling of garbage and waste; air purification and treatment of water; preservation of food and beverages; decontamination of hazardous materials | ACTIVE | — |
| 042 | data encoding services being the encoding and processing of genetic data for genome editing, enzyme optimization, bioprocess development, and strain development in the field of industrial biotechnology. scientific and technological services namely, research and development in the field of genome editing, enzyme optimization, biocatalyst development, bioprocess development, and strain development for industrial biotechnology applications; Testing services, namely, testing the effectiveness and efficiency of microbial strains, fermentation processes, enzymes, proteins, bioactive compounds, and genome editing tools in the field of industrial biotechnology, authentication in the field of biotechnology and quality control in the field of biotechnology for others; design services namely, designing and developing microbial strains, fermentation processes, enzymes, proteins, bioactive compounds, and genome editing tools for industrial biotechnology applications; designing custom biotechnological solutions to optimize production and sustainability in the field of industrial biotechnology; biological analysis; biological research; biological laboratory services; biological research and analysis; biological research, clinical research in the field of industrial biotechnology, namely, conducting studies and trials to evaluate the safety, efficacy, and performance of bio-based products, microbial strains, fermentation processes, enzymes, proteins, and bioactive compounds and medical research; research, namely, research in the fields of genome editing, enzyme optimization, biocatalyst development, bioprocess development, strain development, microbial strains, fermentation processes, bioactive compounds, and sustainability in industrial biotechnology; biomedical research; pharmaceutical research; genetic research; biotechnological research; provision of information on the subject of scientific research in the field of biochemistry and biotechnology; scientific research; research in the field of technology; biochemical research services; chemical research and analysis; medical, biological and biotechnological research laboratory services; computer-assisted scientific research; computer-assisted industrial research, namely, utilizing computer technologies and software for research and development in genome editing, enzyme optimization, biocatalyst development, bioprocess development, strain development, and other areas of industrial biotechnology; biochemical research and analysis; scientific research concerning biology; scientific and industrial research, namely, conducting research and development in the fields of genome editing, enzyme optimization, biocatalyst development, bioprocess development, microbial strains, fermentation processes, and bioactive compounds for applications in industrial biotechnology; scientific research for medical purposes; industrial analysis and research services in the field of biotechnology and biochemistry; medical and pharmaceutical research services; biological research laboratory services; chemical research laboratory services; research in the field of chemistry; pharmaceutical research and development; DNA verification for scientific research purposes; new product development research; gene therapy research; cell separation research; biochemistry research and development; engineering research in scientific fields; chemistry research and development; scientific services and related research, namely, scientific research; scientific research in the field of genetics; research and development in the field of pharmacy and biotechnology; preparation of biological samples for analysis in research laboratories; research and development services in the field of diagnostic agents; research and development services in the field of biotechnology; consulting in the field of biotechnological research; consulting in the field of scientific research; conducting analysis of human tissues for medical research; preparation of biological samples for testing and analysis in research laboratories; research and development services in the field of microorganisms and cells; biochemical analysis; scientific analysis in the nature of analyzing genome editing processes, enzyme efficiency, biocatalyst performance, bioprocesses, microbial strains, fermentation processes, and bioactive compounds for industrial biotechnology applications; technological analysis services in the nature of analyzing genome editing processes, enzyme efficiency, biocatalyst performance, bioprocesses, microbial strains, fermentation processes, and bioactive compounds for industrial biotechnology applications; conducting chemical analysis; analysis in the field of molecular biology; scientific research work in the field of genetics; genetic engineering services; molecular biology work in the nature of conducting research and experiments related to genome editing, genetic modification, enzyme functionality, microbial strain development, and bioactive compound identification for industrial biotechnology applications; DNA modification for scientific research; DNA modification for industrial research; DNA modification for pharmaceutical research; DNA modification for veterinary medical research; DNA modification for medical research; DNA modification for veterinary pharmaceutical research; biological testing, namely, genetic testing for scientific research purposes; biochemical engineering services; biotechnological research in the field of agriculture; biotechnological research in the field of animal husbandry; analytical services in the nature of analyzing and detecting chemical constituents in liquids, including testing for biochemical and molecular components in the fields of genome editing, enzyme optimization, biocatalyst development, and bioprocess development; analytical services in the nature of analysing and determination of the bacterial content in liquids; bacteriological analysis; bacteriological research and analysis; bacteriological research and testing; research consulting, with respect to pharmacogenetics; consulting regarding pharmaceutical research and development; consulting services in the field of bacteriological research; consulting services concerning technological research; consulting services concerning scientific research; biotechnology research in the industrial sector; medical research laboratory services; medical laboratory services; dna testing, for scientific research purposes; chemistry research; biotechnology research; medical research services; bacteriology research and development; research and testing relating to the laboratory research services of bacteriology laboratories and virology; research and development for the pharmaceutical industry; research and development in the field of biotechnology; engineering research in the field of technology; engineering research in the scientific field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; research services related to the development of new products; pharmaceutical development; scientific research in the field of bacteriology; scientific research in the field of pharmaceuticals; scientific research in the field of genetics and genetic engineering; scientific research and development; scientific research using databases; scientific and technological services, namely scientific and technological research in the field of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; industrial analysis and research services in relation to the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; software design and development, for use in the fields of medicine, medical technology, biotechnology, biology, biochemistry and chemistry; consultancy and information relating to the aforesaid services, as included in this class; processing of biological materials, namely, the processing of the genome of all living species, including eukaryotic and prokaryotic species, as well as nucleic acids of all kind ex vivo, including artificial systems comprising nucleic acids for scientific research; transformation of a substance, namely, changes in the genetic information that leads to changes in properties, namely, gene knockout, gene knock-in, changes in gene regulation, changes in gene expression levels, changes in activity of gene products and other related changes in the genetic information for scientific research; chemical bonding for the creation of all sorts of bonds between nucleic acids and proteins for scientific or commercial purposes and custom assembly, cutting and shaping of materials for use in the creation of these bonds; processing of genetic information using biotechnological methods, namely, DNA modification, gene editing, biotechnological engineering, genetic engineering, biochemical engineering | ACTIVE | — |
| 044 | Medical services based on biotechnological methods; veterinary medical services based on biotechnological methods; health and beauty care for humans and animals based on biotechnological methods; agricultural, horticultural or forestry services based on biotechnological methods, namely, the application of biotechnology for enhancing crop yield and resilience, developing pestresistant plant strains, optimizing soil health, improving plant growth through biostimulants, and applying biotechnological solutions for sustainable forestry management; regenerative medicine services; medical analysis services provided by medical laboratories for diagnostic and treatment purposes; medical treatment with cultured cells; medical screening; animal husbandry; DNA testing for medical purposes; medical analysis services performed by a medical laboratory for the treatment of individuals; medical services provided to individuals; medical analysis services related to the treatment of individuals; medical analysis for the diagnosis and treatment of individuals; medical diagnostic services, namely, performing medical tests and analyses; medical services; diabetes medical services; medical care and medical services; medical care and medical services, relating to DNA, genetics and genetic testing; medical services for the treatment of skin; medical services related to the treatment of diseases of the human body; medical care and analysis services related to the treatment of patients; providing information related to medical services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks owned by BRAIN Biotech AG
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named GEDITING
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 29, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 13, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 13, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 28, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 1, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 28, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 28, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 15, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 15, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 14, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 14, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 14, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 4, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 4, 2024 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 4, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 4, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 4, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 4, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 26, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 26, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 14, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 14, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 22, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 16, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 6, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 6, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 6, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 6, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 6, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 22, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 17, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |